What is the price target for HNGE stock?
23 analysts have analysed HNGE and the average price target is 59.1 USD. This implies a price increase of 31.32% is expected in the next year compared to the current price of 45.
NYSE:HNGE • US4333131039
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HINGE HEALTH INC-A (HNGE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-11 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2026-02-11 | Needham | Reiterate | Buy -> Buy |
| 2026-02-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-11 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-11 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-23 | Freedom Capital Markets | Initiate | Buy |
| 2026-01-09 | Wells Fargo | Initiate | Overweight |
| 2026-01-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-01-06 | Needham | Reiterate | Buy -> Buy |
| 2026-01-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-11 | Stifel | Maintains | Buy -> Buy |
| 2025-09-05 | Baird | Initiate | Neutral |
| 2025-08-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-06 | Needham | Maintains | Buy -> Buy |
| 2025-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 292.73M | 390.404M 33.37% | 587.86M 50.58% | 753.5M 28.18% | 894M 18.65% | 1.065B 19.13% | 1.26B 18.31% | 1.44B 14.29% | 1.625B 12.85% | |
| EBITDA YoY % growth | -124.887M | -18.479M 85.20% | -541.238M -2,828.94% | 169.89M 131.39% | 211.49M 24.49% | 232.98M 10.16% | 331.3M 42.20% | 382.6M 15.48% | 435.64M 13.86% | |
| EBIT YoY % growth | -130.514M | -24.429M 81.28% | -546.371M -2,136.57% | 153.76M 128.14% | 194.48M 26.48% | 214.3M 10.19% | 315.89M 47.41% | 364.96M 15.53% | 415.65M 13.89% | |
| Operating Margin | -44.59% | -6.26% | -92.94% | 20.41% | 21.75% | 20.12% | 25.07% | 25.34% | 25.58% | |
| EPS YoY % growth | N/A | N/A | N/A | 1.93 30.48% | 2.31 19.68% | 2.83 22.53% | 3.45 21.78% | 3.87 12.13% | 4.28 10.82% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.38 | 0.44 -38.30% | 0.41 -6.92% | 0.48 -2.98% | 0.39 2.04% | 0.44 0.46% | 0.48 16.62% | 0.56 17.68% |
| Revenue Q2Q % growth | 175.12M 41.43% | 181.92M 30.79% | 185.44M 20.25% | 191.28M 12.04% | 189.74M 8.35% | 196.67M 8.11% | 203.16M 9.56% | 211.63M 10.64% |
| EBITDA Q2Q % growth | 34.096M 136.12% | 39.127M 106.77% | 38.615M 1,868.90% | 45.854M 41.57% | 32.964M -3.32% | 38.49M -1.63% | 43.636M 13.00% | 57.171M 24.68% |
| EBIT Q2Q % growth | 30.577M 132.75% | 35.811M 106.17% | 35.936M 689.79% | 40.721M 49.40% | 34.659M 13.35% | 39.14M 9.30% | 42.632M 18.63% | 51.671M 26.89% |
All data in USD
23 analysts have analysed HNGE and the average price target is 59.1 USD. This implies a price increase of 31.32% is expected in the next year compared to the current price of 45.
The consensus EPS estimate for the next earnings of HINGE HEALTH INC-A (HNGE) is 0.38 USD and the consensus revenue estimate is 175.12M USD.
The expected long term growth rate for HINGE HEALTH INC-A (HNGE) is 22.09%.